Clinical Trial Update: N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis [Phase 2]

View source ↗

Summary

Phase 2 trial of N-acetylcysteine in early-phase schizophrenia spectrum psychosis completed; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Schizophrenic Psychoses | Phase 2 | Status: COMPLETED | Results posted: 2017-06-07